Viimeisimmät kokeilut

EudraCT Number: 2010-020810-27 Sponsor Protocol Number: IB-08-03 Start Date:
Sponsor Name: Laboratoires BOIRON
Full Title: Essai clinique contrôlé randomisé, multicentrique, évaluant l'efficacité de deux médicaments homéopathiques (Dopamine 5 CH et Serotoninum muriaticum 5 CH) chez l'enfant TDAH âgé de 3 à 7 ans (6 ans...
Medical condition: TDAH (Trouble Déficit de l'Attention Hyperactivité)
Disease: Version SOC Term Classification Code Term Level
Population Age: Children, Under 18 Gender: Male, Female
Trial protocol: FR (Ongoing)
Trial results: (No results available)
EudraCT Number: 2018-001771-21 Sponsor Protocol Number: XL184–311 Start Date:
Sponsor Name: Exelixis, Inc.
Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Cabozantinib (XL184) in Subjects with Radioiodine-Refractory Differentiated Thyroid Cancer Who Have Progressed after Prior VEGFR-...
Medical condition: Radioiodine-Refractory Differentiated Thyroid Cancer which has progressed after prior VEGFR-targeted therapy
Disease: Version SOC Term Classification Code Term Level
21.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10066474 Thyroid cancer PT
Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: DE (Ongoing) BE (Ongoing) FR (Ongoing) AT (Ongoing) HU (Ongoing) ES (Ongoing) PL (Ongoing) CZ (Ongoing) HR (Ongoing) GB (GB - no longer in EU/EEA) IT (Ongoing) RO (Ongoing)
Trial results: (No results available)
EudraCT Number: 2022-002012-23 Sponsor Protocol Number: SL79.22 Start Date:
Sponsor Name: STALLERGENES
Full Title: A Multi-national Phase IIIb, Double-blind, Placebo-controlled Trial to Determine the Safety and Efficacy of STALORAL® Birch 300 IR in Children and Adolescents 5 to 17 Years old with Birch Pollen-in...
Medical condition: Birch Pollen-induced Allergic Rhinoconjunctivitis
Disease: Version SOC Term Classification Code Term Level
20.0 100000004853 10001728 Allergic rhinoconjunctivitis LLT
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: SE (Ongoing) FR (Ongoing) FI (Ongoing) DE (Ongoing) LT (Ongoing) SK (Ongoing) HU (Ongoing) BG (Ongoing) AT (Ongoing) LV (Ongoing) PL (Ongoing) RO (Ongoing)
Trial results: (No results available)
EudraCT Number: 2011-004704-38 Sponsor Protocol Number: GBG70 Start Date:
Sponsor Name: GBG Forschungs GmbH
Full Title: Dual blockage with Afatinib and Trastuzumab as neooadjuvant treatment for patients with lo-cally advanced or operable breast cancer receiving taxane-anthracycline containing chemo-therapy (DAFNE st...
Medical condition: Patients with HER2-positive early breast cancer.
Disease: Version SOC Term Classification Code Term Level
14.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10065430 HER-2 positive breast cancer LLT
Population Age: Adults, Elderly Gender: Female
Trial protocol: DE (Completed)
Trial results: (No results available)
EudraCT Number: 2015-004904-50 Sponsor Protocol Number: GWEP15100 Start Date:
Sponsor Name: GW Research Ltd
Full Title: A randomized, double-blind, placebo-controlled trial to investigate the efficacy and safety of Cannabidiol (GWP42003-P) in infants with Infantile Spasms following an initial open label pilot study.
Medical condition: Infantile Spasms
Disease: Version SOC Term Classification Code Term Level
20.1 10029205 - Nervous system disorders 10021750 Infantile spasms PT
Population Age: Infants and toddlers, Under 18 Gender: Male, Female
Trial protocol: PL (Completed)
Trial results: View results
EudraCT Number: 2014-005375-91 Sponsor Protocol Number: NN9535-4216 Start Date:
Sponsor Name: Novo Nordisk A/S
Full Title: Efficacy and safety of semaglutide versus dulaglutide as add-on to metformin in subjects with type 2 diabetes
Medical condition: Diabetes Mellitus, Type 2
Disease: Version SOC Term Classification Code Term Level
18.0 100000004861 10045242 Type II diabetes mellitus LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IE (Completed) FI (Completed) DE (Completed) GB (Completed) SK (Completed) LV (Completed) LT (Completed) GR (Completed) ES (Completed) PT (Completed) HR (Completed)
Trial results: View results
EudraCT Number: 2010-022923-31 Sponsor Protocol Number: FIinTIC Start Date:
Sponsor Name: Medizinische Universität Innsbruck / Univ.-Klinik für Allgem. u. Chirurg. Intensivmedizin
Full Title: A multicenter double-blind, placebo controlled, randomized, pilot trial to assess the efficacy of pre-hospital administration of Fibrinogen Concentrate (FGTW) in trauma patients, presumed to bleed ...
Medical condition: Trauma patients with major bleeding or occult bleeding who received volume replacement
Disease: Version SOC Term Classification Code Term Level
18.0 100000004866 10018988 Haemorrhage NOS LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: AT (Completed) DE (Ongoing) CZ (Ongoing)
Trial results: (No results available)
EudraCT Number: 2021-000214-42 Sponsor Protocol Number: 755-201-EB Start Date:
Sponsor Name: InMed Pharmaceuticals Inc.
Full Title: A Randomised, Double-Blind, Vehicle-Controlled Phase 2 Study of Topically Applied INM-755 (cannabinol) Cream in Patients with Epidermolysis Bullosa.
Medical condition: Epidermolysis bullosa
Disease: Version SOC Term Classification Code Term Level
20.0 10010331 - Congenital, familial and genetic disorders 10014989 Epidermolysis bullosa PT
Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed) FR (Completed) AT (Completed) GR (Ongoing) IT (Ongoing) ES (Ongoing)
Trial results: (No results available)
EudraCT Number: 2022-001624-14 Sponsor Protocol Number: LE3301 Start Date:
Sponsor Name: Pharming Technologies B.V.
Full Title: An Open-Label, Single Arm Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Leniolisib in Pediatric Patients (Aged 4 to 11 Years) With APDS (Activated Phosphoinositide 3-Kina...
Medical condition: Activated Phosphoinositide 3-Kinase Delta Syndrome
Disease: Version SOC Term Classification Code Term Level
20.0 10010331 - Congenital, familial and genetic disorders 10078281 Activated PI3 kinase delta syndrome PT
Population Age: Children, Under 18 Gender: Male, Female
Trial protocol: FR (Ongoing) NL (Ongoing)
Trial results: (No results available)
EudraCT Number: 2004-004988-30 Sponsor Protocol Number: 23386753 Start Date:
Sponsor Name: Mater Misercordiae Hospital - Department of Anaesthesia
Full Title: PHARMACOKINETICS AND ANALGESIC EFFICACY OF LAEVOBUPIVACAINE, FENTANYL AND CLONIDINE FOR POSTOPERATIVE PARAVERTEBRAL ANAESTHESIA.
Medical condition: We are aiming to provide postoperative analgesia for breast surgery
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Female
Trial protocol: IE (Ongoing)
Trial results: (No results available)

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa